Advertisement
UK markets open in 2 hours 46 minutes

  • NIKKEI 225

    37,168.90
    -910.80 (-2.39%)
     

  • HANG SENG

    16,176.95
    -208.92 (-1.27%)
     

  • CRUDE OIL

    84.87
    +2.14 (+2.59%)
     

  • GOLD FUTURES

    2,403.30
    +5.30 (+0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • Bitcoin GBP

    50,168.41
    +250.46 (+0.50%)
     

  • CMC Crypto 200

    1,278.15
    +392.61 (+42.73%)
     

  • NASDAQ Composite

    15,601.50
    -81.87 (-0.52%)
     

  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

Exact Sciences Corp (EXAS) President and CEO Kevin T Conroy Sold $4 million of Shares

GuruFocus.com
·1-min read

- By insider

President and CEO of Exact Sciences Corp (30-Year Financial, Insider Trades) Kevin T Conroy (insider trades) sold 32,819 shares of EXAS on 11/02/2020 at an average price of $121.11 a share. The total sale was $4 million.


Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer. Exact Sciences Corp has a market cap of $18.98 billion; its shares were traded at around $126.15 with and P/S ratio of 14.04. Exact Sciences Corp had annual average EBITDA growth of 6.20% over the past five years. GuruFocus has detected 2 severe warning signs with Exact Sciences Corp. .

ADVERTISEMENT

CEO Recent Trades:

  • President and CEO Kevin T Conroy sold 32,819 shares of EXAS stock on 11/02/2020 at the average price of $121.11. The price of the stock has increased by 4.16% since.

For the complete insider trading history of EXAS, click here

.This article first appeared on GuruFocus.